Human COX7C activation kit by CRISPRa

CAT#: GA100941

COX7C CRISPRa kit - CRISPR gene activation of human cytochrome c oxidase subunit 7C



  See Other Versions

CNY 12255.00


货期*
4周

规格
    • 1 kit

Product images

推荐一起购买 (3)
COX7C (Myc-DDK-tagged)-Human cytochrome c oxidase subunit VIIc (COX7C), nuclear gene encoding mitochondrial protein
    • 10 ug

CNY 1200.00
CNY 3705.00


COX7C rabbit polyclonal antibody
    • 25 ul

CNY 800.00
CNY 1280.00


COX7C rabbit polyclonal antibody
    • 25 ul

CNY 800.00
CNY 1280.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol COX7C
Locus ID 1350
Kit Components

GA100941G1, COX7C gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA100941G2, COX7C gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA100941G3, COX7C gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Reference Data
RefSeq NM_001867
Synonyms cytochrome-c oxidase chain VIIc; cytochrome c oxidase subunit VIIc
Summary Cytochrome c oxidase (COX), the terminal component of the mitochondrial respiratory chain, catalyzes the electron transfer from reduced cytochrome c to oxygen. This component is a heteromeric complex consisting of 3 catalytic subunits encoded by mitochondrial genes and multiple structural subunits encoded by nuclear genes. The mitochondrially-encoded subunits function in electron transfer, and the nuclear-encoded subunits may function in the regulation and assembly of the complex. This nuclear gene encodes subunit VIIc, which shares 87% and 85% amino acid sequence identity with mouse and bovine COX VIIc, respectively, and is found in all tissues. A pseudogene COX7CP1 has been found on chromosome 13. [provided by RefSeq, Jul 2008]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...